Literature DB >> 12665854

Calpain silencing by a reversible intrinsic mechanism.

Tudor Moldoveanu1, Christopher M Hosfield, Daniel Lim, Zongchao Jia, Peter L Davies.   

Abstract

Uncontrolled activation of calpain can lead to necrotic cell death and irreversible tissue damage. We have discovered an intrinsic mechanism whereby the autolysis-generated protease core fragment of calpain is inactivated through the inherent instability of a key alpha-helix. This auto-inactivation state was captured by the 1.9 A Ca(2+)-bound structure of the protease core from m-calpain, and sequence alignments suggest that it applies to about half of the calpain isoforms. Intact calpain large subunits are also subject to this inhibition, which can be prevented through assembly of the heterodimers. Other isoforms or their released cores are not silenced by this mechanism and might contribute to calpain patho-physiologies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12665854     DOI: 10.1038/nsb917

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  22 in total

Review 1.  Calpain research for drug discovery: challenges and potential.

Authors:  Yasuko Ono; Takaomi C Saido; Hiroyuki Sorimachi
Journal:  Nat Rev Drug Discov       Date:  2016-11-11       Impact factor: 84.694

2.  CAPN5 mutation in hereditary uveitis: the R243L mutation increases calpain catalytic activity and triggers intraocular inflammation in a mouse model.

Authors:  Katherine J Wert; Alexander G Bassuk; Wen-Hsuan Wu; Lokesh Gakhar; Diana Coglan; MaryAnn Mahajan; Shu Wu; Jing Yang; Chyuan-Sheng Lin; Stephen H Tsang; Vinit B Mahajan
Journal:  Hum Mol Genet       Date:  2015-05-20       Impact factor: 6.150

3.  Computational investigation of the key factors affecting the second stage activation mechanisms of domain II m-calpain.

Authors:  Gaurav Bhatti; Lakshmi Jayanthi; Pamela VandeVord; Yeshitila Gebremichael
Journal:  J Mol Model       Date:  2012-10-10       Impact factor: 1.810

Review 4.  Calpain-14 and its association with eosinophilic esophagitis.

Authors:  Vladislav A Litosh; Mark Rochman; Jeffrey K Rymer; Aleksey Porollo; Leah C Kottyan; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2017-01-25       Impact factor: 10.793

5.  The N- and C-terminal autolytic fragments of CAPN3/p94/calpain-3 restore proteolytic activity by intermolecular complementation.

Authors:  Yasuko Ono; Mayumi Shindo; Naoko Doi; Fujiko Kitamura; Carol C Gregorio; Hiroyuki Sorimachi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

Review 6.  Emerging roles of calpain proteolytic systems in macrophage cholesterol handling.

Authors:  Takuro Miyazaki; Akira Miyazaki
Journal:  Cell Mol Life Sci       Date:  2017-04-21       Impact factor: 9.261

7.  Electrostatic interactions of domain III stabilize the inactive conformation of mu-calpain.

Authors:  Amaury Fernández-Montalván; Irmgard Assfalg-Machleidt; Dietmar Pfeiler; Hans Fritz; Marianne Jochum; Werner Machleidt
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

8.  Structures of human calpain-3 protease core with and without bound inhibitor reveal mechanisms of calpain activation.

Authors:  Qilu Ye; Robert L Campbell; Peter L Davies
Journal:  J Biol Chem       Date:  2018-01-30       Impact factor: 5.157

9.  Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains.

Authors:  Tudor Moldoveanu; Kalle Gehring; Douglas R Green
Journal:  Nature       Date:  2008-11-20       Impact factor: 49.962

10.  Identification of active Plasmodium falciparum calpain to establish screening system for Pf-calpain-based drug development.

Authors:  Byoung Yul Soh; Hyun-Ok Song; Yoonji Lee; Junghyun Lee; Kusuma Kaewintajuk; Binna Lee; Yun-Young Choi; Jeong Hoon Cho; Sun Choi; Hyun Park
Journal:  Malar J       Date:  2013-02-04       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.